Table 1.

Clinical and pathologic features of 348 ccRCC patients in TMA cohort

Features	n(%)
Age, n(%) ≤65 >65	266 (76.4%) 82 (23.6%)
Tumor size (cm) ≤4 >4	179 (51.4%) 169 (48.6%)
Gender, n(%) Male Female	245 (70.4%) 103 (29.6%)
AJCC stage, n(%) I II III IV	276 (79.3%) 55 (15.8%) 10 (2.8%) 7 (2.1%)
Fuhrman grade, n(%) I II III IV	114 (32.8%) 173 (49.7%) 55 (15.8%) 6 (1.7%)
Tumor Necrosis, n(%)	62 (17.8%)
Death during follow-up, n(%)	71 (20.7%)

ccRCC: clear cell renal cell carcinoma; TMA: tissue microarray